[18F]CETO

N/A

Report date: 2025/11/26 17:11:15
NME

Base Information

Drug Name[18F]CETO
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18FDiagnostic agent (In vivo) > Radionuclide Imaging agent +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsHyperaldosteronismCushing SyndromeAdrenal Gland Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenNetherlandsUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cambridge
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Medical Center GroningenUniversity Of CambridgeCambridge University Hospitals Nhs Foundation Trust +[4] 
Inactive CompaniesN/A
Active IndicationsHyperaldosteronismCushing SyndromeAdrenal Gland Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A